These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6660807)

  • 21. [Correction of metabolic changes in preserved donor blood using hemosorbents].
    Deriabin II; Nikolaev VG; Strelko VV; Belkin AL; Kartel' NT
    Vestn Khir Im I I Grek; 1984 Feb; 132(2):99-102. PubMed ID: 6719735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Morphofunctional properties of an erythrocyte suspension in a preservative based on a solution of modified deionized gelatin].
    Mel'nikova VN; Pleshakov VT; Selivanov EA; Ivanov KP; Kartashevskaia TN
    Gematol Transfuziol; 1988 Jun; 33(6):14-8. PubMed ID: 3169511
    [No Abstract]   [Full Text] [Related]  

  • 23. [A method of erythrocyte cryopreservation with a 20% glycerin content in the cryoprotective solution].
    Mel'nikova VN; Nedel'skiĭ GT; Kuz'min VA; Platonova GG
    Probl Gematol Pereliv Krovi; 1981 Jun; 26(6):9-11. PubMed ID: 7279888
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical implications of red blood cell and platelet storage lesions: an overview.
    Solheim BG; Flesland O; Seghatchian J; Brosstad F
    Transfus Apher Sci; 2004 Dec; 31(3):185-9. PubMed ID: 15556465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Normalization of the physico-chemical properties of blood by hemosorption after its long-term preservation].
    Nikolaev VG; Sigal VL; Belkin AL; Lun'ko AA
    Gematol Transfuziol; 1985 May; 30(5):21-4. PubMed ID: 4018519
    [No Abstract]   [Full Text] [Related]  

  • 26. The two-step preservation of red blood cells. A contribution to improve their viability and therapeutic efficiency.
    Strauss D
    Acta Biol Med Ger; 1981; 40(4-5):721-5. PubMed ID: 7315119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Time limits for preservation of erythrocyte masses at 4 plus or minus 2 degrees C and its suitability for clinical use].
    Petrov MM; Iukhimuk LN; Kushko OV; Diukanova NM
    Probl Gematol Pereliv Krovi; 1982; 27(1):19-21. PubMed ID: 7063454
    [No Abstract]   [Full Text] [Related]  

  • 28. Is it time to focus on preserving the functionality of red blood cells during storage?
    Elfath MD
    Transfusion; 2006 Sep; 46(9):1469-70. PubMed ID: 16965570
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative characteristics of the biophysical state of erythrocytes preserved under different conditions and its evolution in statistical probability concepts].
    Petrov MM; Zhukov NN; Shmakov IuI; Kozachenko MV; Iukhimuk LN
    Gematol Transfuziol; 1983 Jan; 28(1):13-8. PubMed ID: 6832574
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cryogenic preservation of erythrocytes by a droplet freezing technic].
    Sato T
    Hokkaido Igaku Zasshi; 1983 Mar; 58(2):144-53. PubMed ID: 6873868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Rejuvenation of autologous blood preserved by washing in glucose- adenine- phosphate- and citrate-containing solution].
    Matthes G; Richter E; Tofoté U; Pawlow I; Kucera W; Lerche D
    Beitr Infusionsther Transfusionsmed; 1994; 32():498-501. PubMed ID: 9480151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of preserved erythrocytes and activated-preserved erythrocytes with phosphoenolpyruvate on energy metabolism in rat ischemic brain tissue].
    Ueno Y; Hamasaki N; Kimura H; Yamamoto M; Tomonaga M
    No To Shinkei; 2001 Jun; 53(6):551-8. PubMed ID: 11436340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effectiveness of membranotropic substances in the cryopreservation of erythrocytes].
    Lugovoĭ VI; Guseva NR
    Probl Gematol Pereliv Krovi; 1981 Feb; 26(2):41-4. PubMed ID: 7232369
    [No Abstract]   [Full Text] [Related]  

  • 34. [The SAG method: experiences in its use].
    Medarde A
    Sangre (Barc); 1985; 30(4-C):752-7. PubMed ID: 4089746
    [No Abstract]   [Full Text] [Related]  

  • 35. [Current problems in erythrocyte cryopreservation at moderately low temperatures].
    Budennaia MP
    Fiziol Zh (1978); 1983; 29(3):375-6. PubMed ID: 6873347
    [No Abstract]   [Full Text] [Related]  

  • 36. Advances in erythrocyte preservation and hemoglobin substitutes.
    Goodrich RP; Sowemino-Coker SO; Weinstein R
    Curr Opin Hematol; 1994 Mar; 1(2):162-9. PubMed ID: 9371276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative characteristics of an erythrocyte suspension with different plasma-substitute solutions].
    Poliakova LP; Agranenko VA; Suvorova IA; Golubeva VL; Borzova LV
    Probl Gematol Pereliv Krovi; 1980 Jan; 25(1):11-5. PubMed ID: 7367394
    [No Abstract]   [Full Text] [Related]  

  • 38. [The supply of blood and blood components for the clinician].
    Arndt-Hanser A; Schütt KH
    Klin Anasthesiol Intensivther; 1980; 21():80-93. PubMed ID: 7453082
    [No Abstract]   [Full Text] [Related]  

  • 39. [Changes in the content of cations and organophosphorous compounds in erythrocytes after low-temperature (-196 degrees C) preservation under protection of 1,2-propanediol and glycerin].
    Loevskiĭ MM; Vorotilin AM; Gulevskiĭ AK; Belous AM
    Biull Eksp Biol Med; 1982 Sep; 94(9):95-7. PubMed ID: 7171832
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluating red cell recoveries in clinical trials: where should we set the bar?
    Davey RJ
    Transfusion; 2008 Jun; 48(6):1047-8. PubMed ID: 18713108
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.